Magali earned her PhD in 2005 at the Université Paris V René Descartes, France, in Pharmacology, and her second Master’s degree in Pharmaceutical Regulatory Affairs at the Strasbourg Pharmacy School in 2014. In 2010, Magali joined the newly-created Pharmabiotic Research Institute (PRI), which is an industrial-scientific Association dedicated to supporting the field in the development and registration of microbiome-based medicinal products for the European market. Today as Executive Director, she oversees the organization’s EU-wide initiatives in Microbiome Regulatory Science (EU R&I projects, Task Groups, and Microbiome Regulatory Science support) in close collaboration with the PRI membership.